BTBinny Thomas

Binny Thomas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Binny Thomas has a total of 131 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Factors influencing medication management during emergency department-to-home transitions: a qualitative study using the theoretical domains framework

    by Eman Al Hmoud, Raja Barazi, Binny Thomas, Sameer Pathan, Hamde Nazar, Mohamed Izham Mohamed Ibrahim, Muhammad Abdul Hadi

    Introduction: The transition from Emergency department (ED) to home represents a high-risk period in the continuum of patient care, increasing the risk of medication errors, adverse drug events, and poor adherence. This study explored the perspectives of key stakeholder groups on factors influencing medication management during ED-to-home transition, with the goal of informing the design of a pharmacist-led transitional care intervention in the ED. Methods: A qualitative study was conducted with key stakeholders, including physicians, nurses, clinical pharmacists, and patient representatives (patients and Patient and Family Advisory Council (PFAC) members), at a secondary care teaching hospital that manages approximately 161,000 ED visits annually. Data were collected using semi-structured interviews and profession-specific focus groups. Participants were recruited over two months through purposive and snowball sampling. Data were transcribed verbatim and analyzed using a hybrid inductive–deductive approach informed by the Theoretical Domains Framework (TDF). Results: Of the 27 individuals invited, 23 participated (response rate 85%): 19 healthcare professionals and 4 patient representatives. Challenges to medication management stemmed from a combination of system-level factors (e.g., workflow demands, resource and structural gaps, and poorly integrated care transition and communication pathways), healthcare provider-level factors (skills and expertise, role ambiguity, and competing priorities), and patient-level factors (e.g., communication and engagement barriers, and medication adherence challenges). These barriers were predominantly mapped to the TDF domains of Environmental Context and Resources, Social/Professional Role and Identity, Knowledge, Skills, and Social Influences, and collectively hindered key transitional care activities, including medication reconciliation, patient education, and post-discharge care coordination. Conclusion: Suboptimal medication management at ED discharge is driven by multifactorial challenges across the health system, healthcare provider, and patient levels. These findings highlight that multifaceted interventions that optimize the discharge process, enhance care coordination and communication, foster interprofessional collaboration, and support patients in navigating post-ED care may offer potential solutions to improve care transition.

  • Open Access

    Population health outcomes in Qatar 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

    by Abdulqadir J. Nashwan, Hana J. Abukhadijah, Mariam N. Al-Mutawa, Ahmad A. Abujaber, Ameena Jesaimani, Binny Thomas, Abdul Rouf Palli Valapila

  • Open Access

    The prevalence and predictor factors of urinary tract infection in type 2 diabetes mellitus patients receiving SGLT2 inhibitors in Qatar: A retrospective cohort study

    by Shahad H. Alhefel, Binny Thomas, Mohamed Sherbash, Sara Hayder, Mohamed Izham Ibrahim, Rajvir Singh, Ahmad H. Alhefel, Salam Abou Safrah, Ahmed Karawia, Ameena Alyazeedi

    A retrospective cohort study was conducted at two hospitals to evaluate UTI prevalence and predictors in elderly T2DM patients treated with SGLT2 inhibitors. Data from electronic health records over one year were analysed. Patients aged 60 + with a UTI diagnosis within 90 days of starting SGLT2 inhibitors were included. The primary outcome was UTI prevalence; secondary outcomes included factors like age, gender, comorbidities, HbA1c levels, and kidney function. In a cohort of 1,024 elderly T2DM patients, 49% experienced UTIs. Significant predictors included gender, nationality, and age. Females had a higher UTI prevalence (68% vs. 32%, p < 0.001), and Qatari patients had a higher UTI prevalence compared with non-Qatari patients (63% vs. 37%, p = 0.03). Older age was associated with higher UTI risk (p < 0.001). There were no significant associations with HbA1c levels, creatinine levels, or medication duration. Logistic regression confirmed females and older age as significant UTI predictors. These findings highlight demographic factors’ importance in UTI risk among T2DM patients on SGLT2 inhibitors. The study identified varying risks of urinary tract infections (UTIs) among users of SGLT2 inhibitors, influenced by factors like gender, age, and existing health conditions. This underscores the need for cautious prescribing of SGLT2 inhibitors, emphasising personalised risk assessment and careful evaluation of benefits versus risks. Future research should focus on refining UTI risk prediction and developing targeted interventions for this patient population.

  • Open Access

    Population Health Outcomes in Qatar 1990–2023: A Systematic Analysis for the Global Burden of Disease Study 2023

    by Abdulqadir Nashwan, Hana J. Abukhadijah, Mariam N. Al-Mutawa, Ahmad A. Abujaber, Ameena Jesaimani, Benny Thomas, Abdul Rouf Palli Valapila

    Background: Patterns of health and disease in Qatar have shifted substantially over the past three decades, reflecting demographic expansion, economic transition, and significant improvements in health system capacity. A comprehensive, up-to-date evaluation of disease burden is essential to guide priority-setting, resource allocation, and national health planning. However, no prior study has systematically assessed long-term trends in morbidity, mortality, and risk factors in Qatar using the most recent epidemiological data consistent with the Global Burden of Disease (GBD) Study framework. This study addresses this gap by providing a detailed analysis of population health outcomes in Qatar from 1990 to 2023.Methods: We used GBD 2023 estimates to describe temporal trends in mortality, prevalence, incidence, disability-adjusted life years (DALYs), and risk factor–attributable disease burden in Qatar. Data sources included vital registration records, hospital and registry datasets, survey data, and modelled estimates, as needed. Changes were examined across three major cause categories—non-communicable diseases (NCDs), communicable, maternal, neonatal, and nutritional (CMNN) diseases, and injuries—over four analytic periods (1990–2000, 2000–2015, 2015–2023, and 1990–2023). Uncertainty intervals were derived from 250 posterior draws. The study followed GBD guidelines for reporting and estimation transparency.Findings: Qatar has achieved substantial progress in reducing the burden of CMNN diseases since 1990, driven by expanded immunisation coverage, improved maternal and neonatal care, and strengthened primary health services. However, the burden of NCDs has risen markedly and now accounts for the majority of mortality and DALYs. The leading contributors to NCD burden in 2023 were ischemic heart disease, diabetes mellitus, cancer, chronic kidney disease, and neurological disorders. High body-mass index, high fasting plasma glucose, hypertension, dietary risks, and tobacco use were the predominant metabolic and behavioural risk factors. Road traffic injuries remained a leading cause of premature mortality, particularly among young men, reflecting Qatar’s predominantly male working-age expatriate population and high rates of occupational and vehicular mobility. COVID-19 temporarily reversed declines in infectious disease burden during 2020–2021, although trends returned to baseline by 2023.Interpretation: The epidemiological profile of Qatar is characterised by declining infectious disease burden and rising chronic disease and injury burden, shaped by demographic composition and lifestyle transitions. Addressing the growing impact of NCDs and injuries will require sustained preventive strategies, population-level risk factor reduction, strengthened primary care for chronic disease management, and coordinated multisectoral policy responses targeting diet, physical activity, road safety, and occupational health. These findings provide an evidence base to support national health planning and ongoing progress toward equitable and sustainable population health in Qatar.

  • Open Access

    Patients' insights into unused medications during the COVID-19 outbreak: A qualitative study

    by Mutaseim Makki, Asrul Akmal Shafie, Ahmed Awaisu, Rabia Hussain, Moza Al Hail, Walid Mohammed ElMotasim, Mohamed Yousif Mohamed Ali Taha, Einas Abdoun, Noriya Mohd J. Al-Khuzaei, Gamila Salama, et al.

  • Open Access

    Patients’ knowledge, attitude, and practices toward unused medications in Qatar: A cross-sectional survey

    by Mutaseim Makki, Asrul Akmal Shafie, Ahmed Awaisu, Rabia Hussain, Moza Al Hail, Walid Mohammed ElMotasim, Mohamed Yousif Mohamed Ali Taha, Einas Abdoun, Noriya Mohd J. Al-Khuzaei, Gamila Salama, et al.


  • Open Access

    Epidemiology, clinical characteristics, and associated cost of acute poisoning: a retrospective study

    by Waleed Salem, Pallivalappila Abdulrouf, Binny Thomas, Wessam Elkassem, Dina Abushanab, Haseebur Rahman Khan, Yolande Hanssens, Rajvir Singh, Hany A. Zaki, Aftab Mohammed Azad, et al.

    Poisoning is a major public health issue and a leading cause of admission to the emergency department (ED). There is a paucity of data describing the epidemiology and cost of acute poisoning. Therefore, this study investigated the epidemiology, patterns, and associated costs of acute poisoning in emergency department of the largest tertiary care healthcare centre in Qatar. This study was a retrospective review of the health records of patients admitted to the ED due to poisoning between January 2015 and December 2019. Incidence, clinical characteristics, and costs associated with acute poisoning were assessed. Frequency and percentages were calculated for categorical variables and mean and SD for continuous variables. The relationship between sociodemographic characteristics and poisoning profile was assessed using the chi-square test. A micro-costing approach using the cost of each resource was applied for cost calculations. The incidence of acute poisoning was 178 cases per 100,000 patients. Females (56%) and children below 14 years (44.3%) accounted for the largest proportion. Most of the exposures were accidental involving therapeutic agents (64.2%). The mean length of hospital stay was found to be 1.84 ± 0.81 days, and most patients (76.6%) were discharged within the first 8 h. A statistically significant difference was found between age groups and type of toxin (χ2 = 23.3, p < 0.001), cause and route of exposure (χ2 = 42.2, p < 0.001), and length of hospital stay (χ2 = 113.16, p < 0.001). Admission to intensive care units had the highest cost expenditure (USD 326,008), while general wards accounted for the least (USD 57,709). Unintentional poisoning by pharmacological agents is common in infants and children. This study will assist in the development of educational and preventive programmes to minimise exposure to toxic agents. Further studies are required to explore the impact of medical toxicology services, and post discharge monitoring of poisoning.


  • Open Access

    The cost associated with the development of the antimicrobial stewardship program in the adult general medicine setting in Qatar

    by Dina Abushanab, Wafa Al-Marridi, Moza Al Hail, Palli Valappila Abdul Rouf, Wessam ElKassem, Binny Thomas, Hussam Alsoub, Zanfina Ademi, Yolande Hanssens, Rasha El Enany, et al.

    To estimate the economic impact of the developed antimicrobial stewardship program (ASP) versus the preliminary ASP use, in the adults’ general medicine settings in Qatar. Patient records were retrospectively reviewed during two periods: preliminary ASP was defined as the 12 months following ASP implementation (i.e. May 2015-April 2016), and developed ASP was defined as the last 12 months of a 5-year ASP implementation in Hamad Medical Corporation (HMC) (i.e. February 2019-January 2020). The economic impact was the overall cost savings in resource use, including operational costs, plus the cost avoidance associated with ASP. A total of 500 patients were included in the study. The operational costs decreased with the developed ASP. Whereas antimicrobial consumption and resource utilisation, and their associated costs, appear to have declined with the developed ASP, with a cost saving of QAR458 (US$125) per 100-patient beds, the avoided cost was negative, by QAR4,807 (US$1,317) per 100-patient beds, adding to a total QAR4,224 (US$1,160) increase in the 100-patient beds cost after ASP development. Despite that the developed ASP attained a total cost saving QAR458 (US$125) per 100-patient beds, the avoided cost was QAR-4,807 (US$−1,317) per 100-patient beds, which exceeded the cost savings achieved.


  • Open Access

    Behaviour and associated determinants of COVID-19 vaccine acceptance and advocacy: a nationwide survey of pharmacy professionals in Qatar

    by Moza Al Hail, Pallivalapila Abdulrouf, Derek Stewart, Wessam Elkassem, Rajvir Singh, Rasha Al Enany, Aftab Mohammed Azad, Asma Tarannum, Binny Thomas

    Vaccine hesitancy poses a global challenge and is acknowledged to be a complex, multifactorial phenomenon. Of particular concern is hesitancy among health professionals, as this may also impact their advocacy roles. There is a lack of theory-based investigations of pharmacy professionals. The study aims to determine the behaviour and associated determinants influencing pharmacy professionals’ attitude towards vaccine acceptance and advocacy. A cross-sectional survey of 2400 pharmacists and pharmacy technicians at government, semi-government, and private community pharmacies in Qatar. Questionnaire items captured perspectives on COVID vaccine acceptance, advocacy and associated determinants based on the domains and constructs of the Theoretical Domains Framework (TDF). Data were analysed by descriptive and inferential statistics, with TDF items subjected to principal components analysis (PCA). The response rate was 38.6% (927/2400). Almost all (n = 825, 89.0%) were willing to receive the vaccine, which was higher for males (p < 0.001) and those in polyclinics (p < 0.05). PCA of acceptance items gave five components, with response to ‘emotions’ being most negative, associated with acceptance (p < 0.001) and more negative in females (p < 0.001). The majority (n = 799, 86.2%) agreed that it was their professional duty to advocate vaccines. PCA for advocacy items gave two components, with the most negative responses for ‘professional role and identity’, which were more negative for those working in hospitals (p < 0.05). Respondents were least positive regarding emotion-related behavioral determinants for acceptance and professional role and identity for advocacy. Behavior change technique interventions that target these issues have the potential to influence the vaccine hesitancy of pharmacy professionals and other individuals.


  • Open Access

    Investigating physicians’ views on non-formulary prescribing: a qualitative study using the theoretical domains framework

    by Zachariah Nazar, Moza Al Hail, Samaher Al-Shaibi, Tarteel Ali Hussain, Nada Nabil Abdelkader, Abdulrouf Pallivalapila, Binny Thomas, Wessam El Kassem, Yolande Hanssens, Ahmed Mahfouz, et al.

    Background: Well-designed and well-maintained drug formularies serve as a reliable resource to guide prescribing decisions; they are associated with improved medicine safety and increased efficiency, while also serving as a cost-effective tool to help manage and predict medicine expenditure. Multiple studies have investigated the inappropriate prescribing of non-formulary drugs (NFDs) with statistics indicating that up to 70% of NFD usage being inappropriate or not following the ascribed NFD policies. Aim: To explore physicians’ views and influences on their prescribing of non-formulary drugs. Method: Data collection and analysis were underpinned using the Theoretical Domains Framework (TDF). Thirteen semi-structured interviews were conducted within Hamad Medical Corporation, the main provider of secondary and tertiary healthcare in Qatar, with physicians who had submitted a NFD request in the preceding 12 months. Results: Three overarching themes were identified: providing evidence-based care for individual patients; influences of others; and formulary management issues. Subthemes were mapped to specific TDF domains: environmental context and resources; social influences; professional role and identity; beliefs about consequences; goals; intentions. Conclusion: The behavioral influences identified in this study can be mapped to behavior change strategies facilitating the development of an intervention to promote appropriate prescribing of NFDs with implications for medicine safety and healthcare efficiency.